Ikena Oncology

Ikena Oncology company information, Employees & Contact Information

Updated June 2026

Quick answer

Ikena Oncology is a Biotechnology Research company and founded in 2016. It has approximately 22 employees on record. Contact data was last refreshed in June 2026. Find Ikena Oncology's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Ikena merged with ImageneBio in July 2025. Please visit https://inmagenebio.com/ for more information.

Company Details

Employees
22
Founded
2016
Address
645 Summer Street,
Phone
1-857-273-8343
Email
in****@****ogy.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Boston, Massachusetts
Looking for a particular Ikena Oncology employee's phone or email?

Ikena Oncology Questions

News

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals - GlobeNewswire

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals GlobeNewswire

Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Merger with Inmagene Biopharmaceuticals - Yahoo Finance

Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Merger with Inmagene Biopharmaceuticals Yahoo Finance

Ikena Oncology Stockholders Approve Merger With Inmagene Biopharmaceuticals - citybiz

Ikena Oncology Stockholders Approve Merger With Inmagene Biopharmaceuticals citybiz

Ikena Oncology Shareholders Green Light Inmagene Merger: What the 1-for-12 Split Means for Investors - Stock Titan

Ikena Oncology Shareholders Green Light Inmagene Merger: What the 1-for-12 Split Means for Investors Stock Titan

Ikena Oncology and Inmagene Biopharmaceuticals to Merger - citybiz

Ikena Oncology and Inmagene Biopharmaceuticals to Merger citybiz

Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement - GlobeNewswire

Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement GlobeNewswire

Ikena Oncology Announces Strategic Update - Stock Titan

Ikena Oncology Announces Strategic Update Stock Titan

Roche-Acquired Poseida CEO Takes Helm at Ikena-Inmagene Merger with $75M Funding - Stock Titan

Roche-Acquired Poseida CEO Takes Helm at Ikena-Inmagene Merger with $75M Funding Stock Titan

Ikena Appoints Richard Wooster, Ph.D., to its Board of Directors - citybiz

Ikena Appoints Richard Wooster, Ph.D., to its Board of Directors citybiz

Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction - GlobeNewswire

Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction GlobeNewswire

Ikena Appoints Jotin Marango, M.D., Ph.D., as Chief Financial Officer - citybiz

Ikena Appoints Jotin Marango, M.D., Ph.D., as Chief Financial Officer citybiz

Ikena Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update - GlobeNewswire

Ikena Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update GlobeNewswire

Ikena Appoints Michelle Zhang, Ph.D., as Chief Scientific Officer - citybiz

Ikena Appoints Michelle Zhang, Ph.D., as Chief Scientific Officer citybiz

Inmagene Reports Topline Results from Phase 2a Study of - GlobeNewswire

Inmagene Reports Topline Results from Phase 2a Study of GlobeNewswire

Top Ikena Oncology Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant